Global Medical Director, Oncology
GSK
Summary
You will lead global medical activities for one or more oncology assets and work closely with research, commercial, clinical operations, and local medical teams. You will shape evidence generation, guide external scientific engagement, and help translate clinical insights into patient impact.
Job description
Position Summary
You will lead global medical activities for one or more oncology assets and work closely with research, commercial, clinical operations, and local medical teams. You will shape evidence generation, guide external scientific engagement, and help translate clinical insights into patient impact.
Responsibilities
- Lead development and delivery of the global medical affairs plan and the integrated evidence plan for oncology assets.
- Drive above-country medical activities such as advisory boards, congress strategy, symposia, and scientific education.
- Own scientific engagement with external experts, patients, payers and regulators to gather insights and shape strategy.
- Partner with research and development to design and prioritize global and supportive clinical studies, including review of investigator-initiated proposals.
- Support brand and launch planning by providing medical input to local operating companies and commercial teams.
- Provide medical governance and review scientific materials to ensure accuracy, compliance and clear communication.
Basic Qualifications
- MD, PharmD, or PhD with relevant clinical or scientific experience in oncology.
- 5+ years' experience in medical affairs, clinical development, or related roles in Oncology.
- Demonstrated experience leading global medical strategies and evidence generation plans.
- Strong understanding of clinical trial design and operational experience with global studies.
- Experience engaging external experts, advisory boards, and congress planning.
- Excellent written and verbal communication in English and proven ability to present complex data clearly.
Preferred Qualifications
- Deep disease knowledge in lung oncology.
- Experience with expanded access programs or post-approval study requirements.
- Prior experience working across time zones and in a matrix global organization.
- Familiarity with promotional review processes and medical governance standards.
- Track record of publications, abstracts or congress leadership.
- Experience mentoring and developing early-career medical colleagues.
Requirements
- MD, PharmD, or PhD with relevant clinical or scientific experience in oncology.
- 5+ years' experience in medical affairs, clinical development, or related roles in Oncology.
- Demonstrated experience leading global medical strategies and evidence generation plans.
- Strong understanding of clinical trial design and operational experience with global studies.
- Experience engaging external experts, advisory boards, and congress planning.
- Excellent written and verbal communication in English and proven ability to present complex data clearly.
Benefits
- Health Insurance
- Comprehensive Benefits Program
Company overview
GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.